Location
United Kingdom, Europe
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
About Investor
Owen Smith is a Partner at 4BIO Capital in London, focusing on seed and Series A investments of $100 K–$5 M into advanced-therapy ventures, including cell and gene therapies, RNA medicines and targeted therapeutics. He is based in London, England. Since joining 4BIO in 2018, he has supported the seeding and growth of early-stage biotech companies, drawing on his earlier life-science VC roles at Arthurian Life Sciences and Arix Bioscience and his scientific training.
Previous investments
March Biosciences
51M |2024
ViaNautis
25M |2023
Entact Bio
81M |2022
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP